Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307)

Clinical trial NCT03361865 · COMPLETED

Trial details

NCT number: NCT03361865
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

UC (Urothelial Cancer)

Start date: 2017-12-04
Primary completion: 2018-08-09
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.